Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.
about
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer CellsStatus of colitis-associated cancer in ulcerative colitisPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorImmunosuppression associated with chronic inflammation in the tumor microenvironmentAOM/DSS Model of Colitis-Associated CancerGammaH2AX and cancerIBDsite: a Galaxy-interacting, integrative database for supporting inflammatory bowel disease high throughput data analysisCan we change our microbiome to prevent colorectal cancer development?A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates.Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.New Research in Ulcerative Colitis: Optimizing 5-ASA Administration for Efficacy and AdherenceRole of inflammation and inflammatory mediators in colorectal cancerExtraintestinal helminth infection reduces the development of colitis-associated tumorigenesis.Current management of inflammatory bowel disease and colorectal cancer.Epidemiology of cancer of the small intestineColorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer.Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression.Inflammation and colorectal cancer, when microbiota-host mutualism breaks.Dynamic changes and functions of macrophages and M1/M2 subpopulations during ulcerative colitis-associated carcinogenesis in an AOM/DSS mouse modelAssociation between appendectomy and subsequent colorectal cancer development: an Asian population study.Balancing the innate immune system in tumor development.Non-invasive assessment of the efficacy of new therapeutics for intestinal pathologies using serial endoscopic imaging of live miceUygur medicine Xipayi Kui Jie'an affects gene expression profiles in intestinal tissue lesions in a rat model of ulcerative colitis.Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice.One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of ChemopreventionIntestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/+) mouse.Emerging drugs for the treatment of ulcerative colitisColorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis.Celastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition.Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c miceInflammation and colorectal cancer: colitis-associated neoplasia.Preclinical cancer chemoprevention studies using animal model of inflammation-associated colorectal carcinogenesis.Neutrophils: Critical components in experimental animal models of cancer.Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.Dietary modulation of inflammation-induced colorectal cancer through PPARγ.The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature.
P2860
Q26751018-4D2DA25E-5521-4C10-B8BC-469219D5B5C1Q26751745-055B3457-9F84-472E-94D4-96CBAE691EE0Q27022976-1B7DC524-C50D-4853-BC49-6D75B3EF765CQ28083450-FF0E0D6A-CE4D-4EDA-8BFC-9E0105C7C53EQ28829150-9A7063F3-38E1-4211-A781-86D18DB2E3A3Q29614974-52733DBB-F5E8-4666-B426-B44A46F19B5AQ30574616-985B6162-37E5-4D77-B859-6D71A044E9C7Q33360917-D2C32367-8580-4826-BF8A-ECCE8D83A147Q33522055-2F27B3C7-3631-4C75-8B21-2BB2A3CF5846Q33614335-93F95A88-16FF-4CA9-A8D9-B8683939E135Q33822115-3DE21586-61DD-4DBD-97BC-7D4D51BD56CCQ33916287-2CD17A6F-F7EF-4EC1-A741-2BFA13DD99AEQ33957824-58F080D2-CF6D-4569-B2FC-1A95CB2B7677Q34157794-E44DFDBA-D5D5-41F2-9887-662614319524Q34192660-56F5FFBD-FAF5-45F9-A035-727B579E6F70Q34628138-55A68A82-0DF6-4634-AA39-E614A6C1F57DQ34663857-FDEA1D64-E14C-4AF3-9DBE-76C1CFEB4350Q34779174-2967550C-A587-4B82-8E83-AF8F9998FD39Q34876594-99CF3EB6-94BE-4E66-9602-9BDA6066753CQ35103261-C5A8DFCD-3FA9-42BF-9155-D755A0066F9AQ35103691-10E8DACF-BE09-4826-B59C-391E76CC80E3Q35110869-8263359C-847E-4F57-9406-903D049ECE90Q35117711-2A06586A-0037-407D-BFB1-2894563B840AQ35236394-1CAA7B2C-22AE-4F6B-9C8D-F5039F463C66Q35459085-D20BD2F3-16BB-4A69-B123-28A1158B7A87Q35633660-499338C5-6CD9-4192-9A2F-B9B67D9CBF62Q35755629-D3BC81F4-E7ED-4F59-AD9A-C0992C2A9025Q35867147-D9757327-D69C-40AC-93E1-B8A4CA1DEF1FQ36008516-C53E8C73-FDA9-4A88-AC2A-7DEF34788149Q36039436-9E7D64F4-E5BD-4CF0-8FB1-8BFB535EA877Q36144484-054EFF81-7FF2-4C02-879D-E3EA281985F7Q36317435-2B866472-BE08-44B3-A02A-8F99F6A22CF3Q36458235-19896AA0-F276-4B88-BF73-F306F9CE4FE2Q36546684-C76AD92F-433D-484A-B912-87D3189C32D1Q36597803-70A727A7-8D0A-40C5-830F-8ACA57149FC3Q37017072-BBDED846-9309-4242-86A2-2F42260A8F0EQ37070125-D3693D20-F657-4DCA-829C-8F8A80DF860AQ37087479-18A7D749-4897-4D62-9C63-4851C16DA912Q37166674-F4AC1A89-3D67-4B2C-B5A8-D0AA4E9F1646Q37196042-6430C0BD-FD07-48B7-9E48-9549140AFCEB
P2860
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Risk for colorectal cancer in ...... ses and management strategies.
@en
Risk for colorectal cancer in ...... ses and management strategies.
@nl
type
label
Risk for colorectal cancer in ...... ses and management strategies.
@en
Risk for colorectal cancer in ...... ses and management strategies.
@nl
prefLabel
Risk for colorectal cancer in ...... ses and management strategies.
@en
Risk for colorectal cancer in ...... ses and management strategies.
@nl
P2860
P356
P1476
Risk for colorectal cancer in ...... ses and management strategies.
@en
P2093
Laszlo Lakatos
Peter-Laszlo Lakatos
P2860
P304
P356
10.3748/WJG.14.3937
P407
P577
2008-07-01T00:00:00Z